This site is intended for Healthcare Professionals only.

Over half of pregnant women in hospital due to coronavirus were from BAME backgrounds: study

Date:

Share post:

More than half the number of pregnant women who were admitted to UK hospitals with coronavirus were from a black, Asian or minority ethnic (BAME) background, a new study has found.

The peer-reviewed research, published in the British Medical Journal, found that of a total of 427 pregnant women, hospitalised between March 1 and April 14, 233 (56 per cent) were from BAME backgrounds, of which 103 were Asian and 90 were black.

“The high proportion of women from black and other minority ethnic groups admitted to hospital with SARS-CoV-2 in pregnancy is of concern and should be investigated further,” the study by Oxford University’s Nuffield Department of Population Health said.

It noted that “most women did not have severe illness, and most were admitted in the third trimester of pregnancy,” adding: “Transmission of infection to infants of infected mothers may occur but is uncommon.”

It comes as Public Health England stated last week (June 2) that people from BAME backgrounds have a higher risk of dying from coronavirus than white people. The PHE review received criticism from the pharmacy sector for failing to provide any “new insight”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

DHSC Plans to Allow Hub and Spoke Models Across Different Pharmacy Ownerships Soon

It has decided to proceed with the implementation of the two hub and spoke models that it consulted...

NHS Long Term Workforce Plan: 350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places The government has...

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well...

Cipla, Glenmark recall products from US market due to manufacturing issues

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution   Two Indian pharmaceutical companies,...